United States Osteoporosis Drugs Market Report 2016

November 2016 | 119 pages | ID: U79911CDFDAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Osteoporosis Drugs

Revenue, means the sales value of Osteoporosis Drugs

This report studies sales (consumption) of Osteoporosis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Merck & Co
• Eli Lilly
• Amgen
• Abiogen Pharma
• Deltanoid Pharmaceuticals
• F. Hoffmann La Roche
• GlaxoSmithKline
• IMMD
• Ligand Pharmaceuticals
• NPS Pharma
• Pantarhei Bioscience
• Pfizer
• PhytoHealth
• Radius Health
• Shenzhen Haiwang
• Kunming Baker Norton
• Chia Tai Tianqing

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Antiresorptive Medications
• Anabolic Medications
• Others

Split by applications, this report focuses on sales, market share and growth rate of Osteoporosis Drugs in each application, can be divided into

• Hospital use
• Clinic use
• Others

Contents

United States Osteoporosis Drugs Market Report 2016

1 OSTEOPOROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Osteoporosis Drugs
1.2 Classification of Osteoporosis Drugs
  1.2.1 Antiresorptive Medications
  1.2.2 Anabolic Medications
  1.2.3 Others
1.3 Application of Osteoporosis Drugs
  1.3.1 Hospital use
  1.3.2 Clinic use
  1.3.3 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Osteoporosis Drugs (2011-2021)
  1.4.1 United States Osteoporosis Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Osteoporosis Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES OSTEOPOROSIS DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Osteoporosis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Osteoporosis Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Osteoporosis Drugs Average Price by Manufactures (2015 and 2016)
2.4 Osteoporosis Drugs Market Competitive Situation and Trends
  2.4.1 Osteoporosis Drugs Market Concentration Rate
  2.4.2 Osteoporosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OSTEOPOROSIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Osteoporosis Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Osteoporosis Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Osteoporosis Drugs Price by Type (2011-2016)
3.4 United States Osteoporosis Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES OSTEOPOROSIS DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Osteoporosis Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Osteoporosis Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES OSTEOPOROSIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Osteoporosis Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck & Co
  5.2.2 Osteoporosis Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck & Co Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Eli Lilly
  5.3.2 Osteoporosis Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Amgen
  5.4.2 Osteoporosis Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Abiogen Pharma
  5.5.2 Osteoporosis Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Abiogen Pharma Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Deltanoid Pharmaceuticals
  5.6.2 Osteoporosis Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Deltanoid Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 F. Hoffmann La Roche
  5.7.2 Osteoporosis Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 F. Hoffmann La Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 GlaxoSmithKline
  5.8.2 Osteoporosis Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 GlaxoSmithKline Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 IMMD
  5.9.2 Osteoporosis Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 IMMD Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Ligand Pharmaceuticals
  5.10.2 Osteoporosis Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Ligand Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 NPS Pharma
5.12 Pantarhei Bioscience
5.13 Pfizer
5.14 PhytoHealth
5.15 Radius Health
5.16 Shenzhen Haiwang
5.17 Kunming Baker Norton
5.18 Chia Tai Tianqing

6 OSTEOPOROSIS DRUGS MANUFACTURING COST ANALYSIS

6.1 Osteoporosis Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Osteoporosis Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Osteoporosis Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Osteoporosis Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES OSTEOPOROSIS DRUGS MARKET FORECAST (2016-2021)

10.1 United States Osteoporosis Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Osteoporosis Drugs Sales Forecast by Type (2016-2021)
10.3 United States Osteoporosis Drugs Sales Forecast by Application (2016-2021)
10.4 Osteoporosis Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Osteoporosis Drugs
Table Classification of Osteoporosis Drugs
Figure United States Sales Market Share of Osteoporosis Drugs by Type in 2015
Figure Antiresorptive Medications Picture
Figure Anabolic Medications Picture
Figure Others Picture
Table Application of Osteoporosis Drugs
Figure United States Sales Market Share of Osteoporosis Drugs by Application in 2015
Figure Hospital use Examples
Figure Clinic use Examples
Figure Others Examples
Figure United States Osteoporosis Drugs Sales and Growth Rate (2011-2021)
Figure United States Osteoporosis Drugs Revenue and Growth Rate (2011-2021)
Table United States Osteoporosis Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Osteoporosis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Osteoporosis Drugs Sales Share by Manufacturers
Figure 2016 Osteoporosis Drugs Sales Share by Manufacturers
Table United States Osteoporosis Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Osteoporosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Osteoporosis Drugs Revenue Share by Manufacturers
Table 2016 United States Osteoporosis Drugs Revenue Share by Manufacturers
Table United States Market Osteoporosis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Osteoporosis Drugs Average Price of Key Manufacturers in 2015
Figure Osteoporosis Drugs Market Share of Top 3 Manufacturers
Figure Osteoporosis Drugs Market Share of Top 5 Manufacturers
Table United States Osteoporosis Drugs Sales by Type (2011-2016)
Table United States Osteoporosis Drugs Sales Share by Type (2011-2016)
Figure United States Osteoporosis Drugs Sales Market Share by Type in 2015
Table United States Osteoporosis Drugs Revenue and Market Share by Type (2011-2016)
Table United States Osteoporosis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Osteoporosis Drugs by Type (2011-2016)
Table United States Osteoporosis Drugs Price by Type (2011-2016)
Figure United States Osteoporosis Drugs Sales Growth Rate by Type (2011-2016)
Table United States Osteoporosis Drugs Sales by Application (2011-2016)
Table United States Osteoporosis Drugs Sales Market Share by Application (2011-2016)
Figure United States Osteoporosis Drugs Sales Market Share by Application in 2015
Table United States Osteoporosis Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Osteoporosis Drugs Sales Growth Rate by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Osteoporosis Drugs Sales Market Share (2011-2016)
Table Merck & Co Basic Information List
Table Merck & Co Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co Osteoporosis Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Osteoporosis Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Osteoporosis Drugs Sales Market Share (2011-2016)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abiogen Pharma Osteoporosis Drugs Sales Market Share (2011-2016)
Table Deltanoid Pharmaceuticals Basic Information List
Table Deltanoid Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Deltanoid Pharmaceuticals Osteoporosis Drugs Sales Market Share (2011-2016)
Table F. Hoffmann La Roche Basic Information List
Table F. Hoffmann La Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann La Roche Osteoporosis Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Osteoporosis Drugs Sales Market Share (2011-2016)
Table IMMD Basic Information List
Table IMMD Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table IMMD Osteoporosis Drugs Sales Market Share (2011-2016)
Table Ligand Pharmaceuticals Basic Information List
Table Ligand Pharmaceuticals Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ligand Pharmaceuticals Osteoporosis Drugs Sales Market Share (2011-2016)
Table NPS Pharma Basic Information List
Table NPS Pharma Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NPS Pharma Osteoporosis Drugs Sales Market Share (2011-2016)
Table Pantarhei Bioscience Basic Information List
Table Pantarhei Bioscience Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pantarhei Bioscience Osteoporosis Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Osteoporosis Drugs Sales Market Share (2011-2016)
Table PhytoHealth Basic Information List
Table PhytoHealth Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table PhytoHealth Osteoporosis Drugs Sales Market Share (2011-2016)
Table Radius Health Basic Information List
Table Radius Health Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Radius Health Osteoporosis Drugs Sales Market Share (2011-2016)
Table Shenzhen Haiwang Basic Information List
Table Shenzhen Haiwang Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shenzhen Haiwang Osteoporosis Drugs Sales Market Share (2011-2016)
Table Kunming Baker Norton Basic Information List
Table Kunming Baker Norton Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kunming Baker Norton Osteoporosis Drugs Sales Market Share (2011-2016)
Table Chia Tai Tianqing Basic Information List
Table Chia Tai Tianqing Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chia Tai Tianqing Osteoporosis Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Osteoporosis Drugs
Figure Manufacturing Process Analysis of Osteoporosis Drugs
Figure Osteoporosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Osteoporosis Drugs Major Manufacturers in 2015
Table Major Buyers of Osteoporosis Drugs
Table Distributors/Traders List
Figure United States Osteoporosis Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Osteoporosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Osteoporosis Drugs Production Forecast by Type (2016-2021)
Table United States Osteoporosis Drugs Consumption Forecast by Application (2016-2021)